Skip to main content

Advertisement

SpringerLink
Log in

Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

We evaluated high-risk human papillomavirus (HR-HPV) DNA testing for high-grade cervical intraepithelial neoplasia (CIN) lesions by cobas HPV test and diagnostic HPV16/18 genotyping in Japanese women with low-grade squamous intraepithelial lesions. Of 357 patients, HR-HPV positivity prevalence was 75.6%, and 21.3% had grade 2 or higher CIN lesions (CIN2+), with the highest prevalence at 30 to 34 years. Negative predictive values of HR-HPV for CIN2+ in our patients were 93.1% (any age) and 94.9% (40–50 years). Absolute risk for CIN2+ in HR-HPV positive and HPV16/18 positive individuals was 25.9 and 35.1, respectively. Relative risk for CIN2+ lesions was 5.1 for HPV16/18 positive versus HR-HPV negative, and 3.8 for HR-HPV positive versus HR-HPV negative women. Predictive values of CIN2+ positive were higher for HPV16/18 positive women (any age) than 12 other HPV positive-genotypes, and highest (50%) at 40–50 years. The HPV16/18 genotyping might prevent women (>40 years) at risk of high-grade CIN lesions from undergoing unnecessary colposcopy/overtreatment of nonprogressive lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Insinga RP, Glass AG, Rush BB. Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol. 2004;191(1):105–113.

    PubMed  Google Scholar 

  2. Hosaka M, Fujita H, Hanley SJ, et al. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women. Int J Cancer. 2012;132(2):327–334.

    PubMed  Google Scholar 

  3. Hariri S, Unger ER, Sternberg M, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003–2006. J Infect Dis. 2011;204(4):566–573.

    PubMed  Google Scholar 

  4. Levi AW, Harigopal M, Hui P, Schofield K, Chhieng DC Use of high-risk human papillomavirus testing in patients with low-grade squamous intraepithelial lesions. Cancer Cytopathol. 2011;119(4):228–234.

    PubMed  Google Scholar 

  5. Matsumoto K, Hirai Y, Furuta R, et al. Subsequent risks for cervical precancer and cancer in women with low-grade squamous intraepithelial lesions unconfirmed by colposcopy-directed biopsy: results from a multicenter, prospective, cohort study. Int J Clin Oncol. 2012;17(3):233–239.

    PubMed  Google Scholar 

  6. ALTS Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol. 2003;188(6):1393–1400.

    Google Scholar 

  7. Ince U, Aydin O, Peker O. Clinical importance of ‘‘low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)’’ terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literature. Gynecol Oncol. 2011;121(1):152–156.

    PubMed  Google Scholar 

  8. Moscicki AB, Ma Y, Wibbelsman C, et al. Rate of and risk for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynaecol. 2010;116(6):1373–1380.

    Google Scholar 

  9. de Sanjose S, Quint WG, Alemany L, et al. Human papilloma-virus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11): 1048–1056.

    PubMed  Google Scholar 

  10. Miura S, Matsumoto K, Oki A, et al. Do we need a different strategy for HPV screening and vaccination in East Asia? Int J Cancer. 2006;119(11):2713–2715.

    CAS  PubMed  Google Scholar 

  11. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52(6):342–362.

    PubMed  Google Scholar 

  12. The Atypical Squamous Cells of Undetermined Significance/ Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst. 2000;92(5):397–402.

    Google Scholar 

  13. Wright TC Jr, Stoler MH, Behrens CM, Apple R, Derion T, Wright TL. The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol. 2012; 206(1):46. e1–e11.

    Google Scholar 

  14. Ronco G, Cuzick J, Segnan N, et al. HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. Eur J Cancer. 2007;43(3):476–480.

    PubMed  Google Scholar 

  15. Cuzick J, Thomas Cox J, Zhang G, et al. Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions. Int J Cancer. 2013;132(4):959–966.

    CAS  PubMed  Google Scholar 

  16. Correa F de M, Russomano FB, Oliveira CA. Colposcopic triage methods for detecting cervical intraepithelial neoplasia grade 3 after cytopathological diagnosis of low-grade squamous intraepithelial lesion: a systematic review on diagnostic tests. Sao Paulo Med J. 2012;130(1):44–52.

    Google Scholar 

  17. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Report of the 1991 Bethesda Workshop. Am J Surg Pathol. 1992;16(9):914–916.

    Google Scholar 

  18. Kurman RJ, Ellenson LH, Ronnett BM. Blaustein’s Pathology of the Female Tract. New York: Springer; 2011:273–274.

    Google Scholar 

  19. Arbyn M, Roelens J, Cuschieri K, et al. The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy. Int J Cancer. 2013;132(1):101–108.

    CAS  PubMed  Google Scholar 

  20. Mesher D, Szarewski A, Cadman L, et al. Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities. Eur J Cancer. 2013; 49(9):2179–2186.

    PubMed  Google Scholar 

  21. Szarewski A, Mesher D, Cadman L, et al. Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study. J Clin Microbiol. 2012;50(6):1867–1873.

    PubMed  PubMed Central  Google Scholar 

  22. Austin RM, Zhao C. Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening? Cytojournal. 2014;11:14.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

    Takashi Iwata MD, PhD, Toshihiko Hasegawa MD, PhD, Kazunori Ochiai MD, PhD, Ken Takizawa MD, PhD, Satoshi Umezawa MD, PhD, Hiroyuki Kuramoto MD, PhD, Mineo Ohmura MD, PhD, Kaneyuki Kubushiro MD, PhD, Hiroharu Arai MD, PhD, Masaru Sakamoto MD, PhD, Teiichi Motoyama MD, PhD, Kayoko Watanabe BS & Daisuke Aoki MD, PhD

Authors
  1. Takashi Iwata MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshihiko Hasegawa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazunori Ochiai MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ken Takizawa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Satoshi Umezawa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiroyuki Kuramoto MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mineo Ohmura MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kaneyuki Kubushiro MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hiroharu Arai MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Masaru Sakamoto MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Teiichi Motoyama MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Kayoko Watanabe BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Daisuke Aoki MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takashi Iwata MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iwata, T., Hasegawa, T., Ochiai, K. et al. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions. Reprod. Sci. 22, 1509–1515 (2015). https://doi.org/10.1177/1933719115589408

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719115589408

Keywords

Search

Navigation